Tatva Chintan Pharma Chem Ltd posts Rs. 9.50 crores consolidated PAT in Q1FY24

Tatva Chintan Pharma Chem Ltd has reported Consolidated financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 115.379 crores during the period ended June 30, 2023 as compared to Rs. 125.356 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 9.504 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 16.954 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 4.29 for the period ended June 30, 2023 as compared to Rs. 7.65 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 115.379 crs	₹125.356 crs	-7.96%
Net Profit	₹9.504 crs	₹16.954 crs	-43.94%
EPS	₹4.29	₹7.65	-43.92%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 115.379 crores during the period ended June 30, 2023 as compared to Rs.90.277 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.9.504 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.9.797 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.4.29 for the period ended June 30, 2023 as compared to Rs.4.42 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 115.379 crs	₹90.277 crs	27.81%
Net Profit	₹9.504 crs	₹9.797 crs	-2.99%
EPS	₹4.29	₹4.42	-2.94%

Shares of Tatva Chintan Pharma Chem Ltd was last trading in BSE at Rs. 1688.70 as compared to the previous close of Rs. 1668.80. The total number of shares traded during the day was 1649 in over 270 trades.

The stock hit an intraday high of Rs. 1697.00 and intraday low of 1663.00. The net turnover during the day was Rs. 2759522.00.

Source : Equity Bulls

Keywords

TatvaChintanPharmaChem Q1FY24 ResultUpdate